Muscle Tension Dysphonia Treatment Market Size & Share, by Treatment Type (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Proton-pump Inhibitors, Analgesics, Antacids, Voice Therapy, Behavioural Counseling); Age Group (Pediatrics, Adults, Elderly); Distribution Channel (Hospitals, Clinics, Retails, Specialized Centers, Retail Pharmacies, Online Pharmacies) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5631
  • Published Date: Feb 12, 2024
  • Report Format: PDF, PPT

Companies Dominating the Muscle Tension Dysphonia Treatment Market

top-features-companies
    • Verboso LLC
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • SpeakSuite, Inc.
    • Pfizer Inc.
    • Cipla Inc.
    • Merck & Co., Inc.
    • Astellas Pharma Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • A new virtual speech treatment platform powered by speech recognition has been introduced by Verboso, a former recipient of the Microsoft AI for Accessibility grant. It takes an inventive approach to online speech therapy. In-person sessions with a professional and licensed speech-language pathologist are combined with unique games that each client's therapist tailors to their own needs to provide feedback for at-home practice. With the use of speech recognition software, these specifically created games for speech therapy facilitate the practice of the correct speech patterns that are taught during sessions.
  • SpeakSuite is raising the standard for speech-therapy support services as it enters its second year in the North American market. SpeakSuite is pleased to announce the introduction of its first significant platform update. The revolutionary platform was introduced in 2022 to enable speech therapy treatment. These innovations redesigned the user experience and set the stage for a time of significant expansion, coming after a rebrand and the appointment of a new CEO earlier this summer.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5631
  • Published Date: Feb 12, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing sponsored research and development activities by the government, growing demand for personalized diagnostic techniques, and increased stress among adults and children are the major factors driving the growth of the muscle tension dysphonia treatment market.

The market size of muscle tension dysphonia treatment is anticipated to attain a CAGR of 3% over the forecast period, i.e., 2024-2036.

The major players in the market are Verboso LLC, SpeakSuite, Inc., Pfizer Inc., Cipla Inc., Merck & Co., Inc., Astellas Pharma Inc., Daiichi Sankyo Co Ltd., Takeda Pharmaceutical Co Ltd., CoeFont Inc., Teijin Ltd., Otsuka Holdings Co Ltd., and others.

The adult segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying